Rain Therapeutics Initiates Phase 3 MANTRA Clinical Trial of Milademetan for De-differentiated Liposarcoma and Provides Patient Update from Prior Clinical Program

Ads

You May Also Like

PET/CT cancer examinations will be available at LJMC

Latvia, 2017-01-24 06:08 CET (GLOBE NEWSWIRE) -- Starting from this spring, it will be ...

Power Up with Plant Protein

MISSION, Kan., Sept. 01, 2017 (GLOBE NEWSWIRE) -- (Family Features) When it comes to ...